The inhibition of PRMT5 in tumor tissues can trigger DNA damage, defects in DNA repair, and activation of the p53 signaling pathway, leading to cell cycle arrest and cell death [8,9,22,23]. The gene discussed is PRMT5; the disease is neoplasm.